Literature DB >> 1530617

Interleukin 6/B cell stimulatory factor-II is expressed and released by normal and transformed human bronchial epithelial cells.

H Takizawa1, T Ohtoshi, K Ohta, S Hirohata, M Yamaguchi, N Suzuki, T Ueda, A Ishii, G Shindoh, T Oka.   

Abstract

Airway epithelial cells have a potential to participate in local immune and inflammatory responses via releasing biologically active compounds. We studied the expression and release of interleukin 6 (IL-6), a multifunctional cytokine possibly involved in tissue immune responses. Primary culture of normal human bronchial epithelial cells and its transformed cell line BEAS-2B released significant amount of biologically and immunologically intact IL-6 into media. A protein synthesis inhibitor cycloheximide abolished the IL-6 release, suggesting a de novo synthesis. Northern blot analysis demonstrated the expression of the specific IL-6 mRNA. Human bronchial epithelial cells can produce IL-6 and contribute to the local activity of IL-6, suggesting that these cells may play a role in the regulation of airway immune responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530617     DOI: 10.1016/0006-291x(92)91236-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Epithelial, dendritic, and CD4(+) T cell regulation of and by reactive oxygen and nitrogen species in allergic sensitization.

Authors:  Karina Ckless; Samantha R Hodgkins; Jennifer L Ather; Rebecca Martin; Matthew E Poynter
Journal:  Biochim Biophys Acta       Date:  2011-03-21

2.  Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro.

Authors:  S Kawasaki; H Takizawa; T Ohtoshi; N Takeuchi; T Kohyama; H Nakamura; T Kasama; K Kobayashi; K Nakahara; Y Morita; K Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 3.  Airway epithelial regulation of allergic sensitization in asthma.

Authors:  Matthew E Poynter
Journal:  Pulm Pharmacol Ther       Date:  2012-05-09       Impact factor: 3.410

Review 4.  Models for oral uptake of nanoparticles in consumer products.

Authors:  Eleonore Fröhlich; Eva Roblegg
Journal:  Toxicology       Date:  2011-11-18       Impact factor: 4.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.